Beth King: What Makes Stago Different From Every Other Vendor in Hemostasis?
Beth King, Portfolio Partnership Executive at Stago, shared a post on LinkedIn:
”What makes Stago different from every other vendor in hemostasis?
1. Hemostasis is all we do.
It isn’t one part of a larger diagnostics portfolio—it is our focus. We take coagulation seriously, and that commitment shows in our instrumentation, reagents, service, support, and expertise.
2. Our people make the difference.
From our sales team and applications specialists to our service engineers and leadership, we are dedicated to our customers and their laboratories. Many of us come from the laboratory ourselves, so we understand the challenges laboratorians face every day.
3. We make coagulation simpler.
Our goal is to help laboratories work efficiently, confidently, and accurately—without unnecessary complexity.
4. Our technology truly sets us apart.
Stago’s mechanical, viscosity-based clot detection is not dependent on optical clot detection. That means hemolysis, icterus, and lipemia do not create the same interference challenges associated with photometric systems.
Your staff should not have to spend valuable time interpreting questionable clot curves or wondering whether the appearance of a sample is preventing them from obtaining the critical coagulation result a patient needs.
That is the Stago Difference.
We are Stago 3.0.
Make it simple.
Make it Stago.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients